Dacryoscintigraphy for the detection of ocular drainage system stenosis induced by docetaxel and fluorouracil

Hellenic Journal of Nuclear Medicine

Volumn 15, Issue 2, 2012, Pages 159-161

  Tsoucalas, Gregory I ^a   Tzovaras, Alexandros A ^a   Ntokou, Anna P ^a   Markos, Lambros I ^a   Sarafianou, Eleni N ^a  

^a SAINT SAVVAS HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL TEAR; CAPECITABINE; CARBOPLATIN; DEXAMETHASONE; DOCETAXEL; FLUOROURACIL; PERTECHNETIC ACID TC 99M;

ADULT; BREAST CANCER; CASE REPORT; DACRYOSCINTIGRAPHY; DIAGNOSTIC TEST; DRUG WITHDRAWAL; EPIPHORA; EYE DISCOMFORT; EYE EXAMINATION; FEMALE; HUMAN; LACRIMAL DUCT; LACRIMAL DUCT OCCLUSION; LETTER; MALE; METASTASIS; MULTIPLE CYCLE TREATMENT; PATIENT MONITORING; STOMACH CARCINOMA;

ANTINEOPLASTIC AGENTS; CONSTRICTION, PATHOLOGIC; EYE DISEASES; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; TAXOIDS;

EID: 84865330425     PISSN: 17905427     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (25)

1. Valero V. Docetaxel as single-agent therapy in metastatic breast cancer: clinical efficacy. Semin Oncol 1997; 24(4 Suppl 13): 11-8.
2. Picus J, Schultz M. Docetaxel (Taxotere) as monotherapy in the treatment of hormone-refractory prostate cancer: preliminary results. Semin Oncol 1999; 26(5 Suppl 17): 14-8.
3. Nakamura T, Fuwa N, Takayama K et al. Phase I study of weekly docetaxel and cisplatin arterial infusion for recurrent head and neck cancer. Head Neck 2011. doi: 10.1002/hed.21983. [Epub ahead of print].
4. Khokhar NZ, Jiang Y, Benson AB 3rd et al. Refining docetaxel-containing therapy for gastric cancer. Gastrointest Cancer Res 2011; 4(3): 96-105.
5. Bedard PL, Di Leo A, Piccart-Gebhart MJ. Taxanes: optimizing adjuvant chemotherapy for early-stage breast cancer. Nat Rev Clin Oncol 2010; 7(1): 22-36.
6. Ferraresi V, Milella M, Vaccaro A et al. Toxicity and activity of docetaxel in anthracycline-pretreated breast cancer patients: a phase II study. Am J Clin Oncol 2000; 23(2): 132-9.
7. Esmaeli B, Valero V, Ahmadi MA, Booser D. Canalicular stenosis secondary to docetaxel (taxotere): a newly recognized side effect. Ophthalmology 2001; 108(5): 994-5.
8. Calonge M. The treatment of dry eye. Surv Ophthalmol 2001; 45(Suppl 2): S227-39.
9. Esmaeli B, Ahmadi MA, Rivera E et al. Docetaxel secretion in tears: association with lacrimal drainage obstruction. Arch Ophthalmol 2002; 120(9): 1180-2.
10. Esmaeli B, Burnstine MA, Ahmadi MA, Prieto VG. Docetaxel-induced histologic changes in the lacrimal sac and the nasal mucosa. Ophthal Plast Reconstr Surg 2003; 19(4): 305-8.
11. Ahmadi MA, Esmaeli B. Surgical treatment of canalicular stenosis in patients receiving docetaxel weekly. Arch Ophthalmol 2001; 119(12): 1802-4.
12. Chung YA, Yoo IeR, Oum JS et al. The clinical value of dacryoscintigraphy in the selection of surgical approach for patients with functional lacrimal duct obstruction. Ann Nucl Med 2005; 19(6): 479-83.
13. Eisner A, Luoh SW. Breast cancer medications and vision: effects of treatments for early-stage disease. Curr Eye Res 2011; 36(10): 867-85.
14. Esmaeli B, Amin S, Valero V et al. Prospective study of incidence and severity of epiphora and canalicular stenosis in patients with metastatic breast cancer receiving docetaxel. J Clin Oncol 2006; 24(22): 3619-22.
15. Weber RK, Keerl R, Schaefer SxD, Della Rocca RC. Atlas of lacrimal surgery. Springer, Berlin, 2007; 6.
16. Von Denffer H, Dressler J, Pabst HW. Lacrimal dacryoscintigraphy. Semin Nucl Med 1984; 14(1): 8-15.
17. Brown M, El Gammal TA, Luxenberg MN, Eubig C. The value, limitations, and applications of nuclear dacryocystography. Semin Nucl Med 1981; 11(4): 250-7.
18. Prasad S, Kamath GG, Phillips RP. Lacrimal canalicular stenosis associated with systemic 5-fluorouacil therapy. Acta Ophthalmol Scand 2000; 78(1): 110-3.
19. Christophidis N, Vajda FJ, Lucas I, Louis WJ. Ocular side effects with 5-fluorouracil. Aust N Z J Med 1979; 9(2): 143-4.
20. Bakri SJ, Carney AS, Robinson K et al. Quality of life outcomes following dacryocystorhinostomy: external and endonasal laser techniques compared. Orbit 1999; 18(2): 83-8.
21. Leyssens B, Wildiers H, Lobelle JP et al. A double-blind randomized phase II study on the efficacy of topical eye treatment in the prevention of docetaxel-induced dacryostenosis. Ann Oncol 2010; 21(2): 419-23.
22. Gontier J, Fisch U. Schirmer's test: its normal values and clinical significance. ORL J Otorhinolaryngol Relat Spec 1976; 38(1): 1-10.
23. Lew H, Lee SY, Kim SJ: The clinical evaluation on the patients complaining of epiphora. J Korean Ophthalmol Soc 2000; (41): 1112-7.
24. Denffer H, Dressler J, Pabst HW. Lacrimal dacryoscintigraphy. Seminars in Nuclear Medicine 1984; 14(1): 8-15.
25. Nagi KS, Meyer DR. Utilization patterns for diagnostic imaging in the evaluation of epiphora due to lacrimal obstruction: a national survey. Ophthal Plast Reconstr Surg 2010; 26(3): 168-71.